OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Coveler on SEA-CD40 Combo in Metastatic Pancreatic Ductal Adenocarcinoma

June 16th 2020

Andrew Coveler, MD, discusses the investigational CD40-directed monoclonal antibody SEA-CD40 in combination with gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma.

Dr. Glitza Oliva on Intrathecal/Intravenous Nivolumab in Metastatic Melanoma/Leptomeningeal Disease

June 16th 2020

Isabella C. Glitza Oliva, MD, PhD, MS, discusses the rationale for concurrent intrathecal and intravenous nivolumab in patients with metastatic melanoma who have leptomeningeal disease.

Dr. Branagan on Novel Induction Therapies With Transplant in Myeloma

June 16th 2020

Andrew Branagan, MD, discusses novel induction therapies being used with transplant to improve outcomes in patients with multiple myeloma.

Dr. Furman on the Safety of Acalabrutinib in Hematologic Malignancies

June 16th 2020

Richard R. Furman, MD, discusses the safety of acalabrutinib as a monotherapy in hematologic malignancies.

Dr. Karmali on Treating Older Patients With MCL in the Rituximab Era

June 16th 2020

Reem Karmali, MD, MS, discusses an analysis examining clinical outcomes and predictors of survival in older patients with mantle cell lymphoma in the era of rituximab.

Dr. Coleman on the Utility of Biomarkers for Precision Medicine in Ovarian Cancer

June 16th 2020

Robert L. Coleman, MD, FACOG, FACS, discusses the utility of biomarkers in precision medicine.

Dr. Gwin on Potential Areas of Investigation With Alpha-TEA/Trastuzumab in Breast Cancer

June 16th 2020

William R. Gwin III, MD, discusses potential areas of investigation with the combination of alpha-tocopheryloxyacetic acid (alpha-TEA) and trastuzumab (Herceptin) in breast cancer.

Dr. Hari on the Current and Potential Future Utility of Ixazomib Maintenance in Myeloma

June 16th 2020

Parameswaran Hari, MD, MRCP, discusses the current and potential future utility of ixazomib (Ninlaro) maintenance in multiple myeloma.

Dr. Kumar on Takeaways From the ENDURANCE Trial in Multiple Myeloma

June 16th 2020

Shaji K. Kumar, MD, discusses key takeaways from the phase 3 ENDURANCE trial in newly diagnosed multiple myeloma.

Dr. Lee on Examining Novel Targets in Lymphomas and Leukemias

June 15th 2020

Hun Ju Lee, MD, discusses novel targets in lymphomas and leukemias.

Dr. Berdeja on Updated CARTITUDE-1 Results With JNJ-4258 in Multiple Myeloma

June 15th 2020

Jesus G. Berdeja, MD, discusses updated safety results from the ongoing phase 1b/2 CARTITUDE-1 trial (NCT03548207) with the CAR T-cell therapy JNJ-4528 in multiple myeloma.

Dr. Morris on the Promise of PSMA-Targeted PET Imaging in Prostate Cancer

June 15th 2020

Michael J. Morris, MD, discusses the promising future of prostate-specific membrane antigen–targeted PET imaging in prostate cancer.

Dr. Jain on the Activity of Venetoclax in MCL

June 15th 2020

Preetesh Jain, MD, PhD, discusses the activity of venetoclax (Venclexta) in mantle cell lymphoma (MCL).

Dr. Awad on Acquired Resistance to MET Inhibitors in NSCLC

June 15th 2020

Mark M. Awad, MD, PhD, discusses acquired resistance to MET inhibitors in MET exon 14 skipping (METex14)–mutated non–small cell lung cancer (NSCLC).

Dr. Ruan on the Impact of BTK Inhibitors in MCL

June 15th 2020

Jia Ruan, MD, PhD, discusses the impact of BTK inhibitors in mantle cell lymphoma (MCL).

Dr. Sharman on Unmet Clinical Needs in High-Risk Relapsed/Refractory CLL

June 15th 2020

Jeff P. Sharman, MD, discusses unmet clinical needs in the treatment of patients with high-risk relapsed/refractory chronic lymphocytic leukemia.

Dr. Yardley on Treatment Considerations in Patients With Advanced Breast Cancer and Visceral Metastases

June 15th 2020

Denise Yardley, MD, discusses treatment considerations for patients with advanced breast cancer who have visceral metastases.

Dr. Slomovitz on the Importance of Developing Sequencing Strategies in Endometrial Cancer

June 15th 2020

Brian M. Slomovitz, MD, discusses the importance of developing sequencing strategies in endometrial cancer treatment.

Dr. Polsky on the Association Between ctDNA and Survival in Melanoma

June 11th 2020

David Polsky, MD, PhD, on the association between circulating tumor DNA and survival in melanoma.

Dr. Mizrahi on Addition of PARP Inhibitors to Chemotherapy in Mutated Pancreatic Cancer

June 11th 2020

Jonathan Mizrahi, MD, discusses the addition of veliparib to chemotherapy in BRCA1/2 or PALB2-mutated pancreatic cancer.